vs
LEGALZOOM.COM, INC.（LZ）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
LEGALZOOM.COM, INC.的季度营收约是再鼎医药的1.5倍（$190.3M vs $127.1M），LEGALZOOM.COM, INC.同比增速更快（17.7% vs 17.1%），LEGALZOOM.COM, INC.自由现金流更多（$28.0M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs 4.5%）
LegalZoom是2001年成立的美国在线法律科技与服务企业，依托独立律师网络、旗下自营律所，结合自助服务技术与专属顾问，为用户提供线上法律服务。核心业务涵盖遗嘱、生前信托设立，营业执照、许可证办理等商事合规服务，以及版权登记、商标申请，同时还提供律师推荐等相关配套服务。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
LZ vs ZLAB — 直观对比
营收规模更大
LZ
是对方的1.5倍
$127.1M
营收增速更快
LZ
高出0.5%
17.1%
自由现金流更多
LZ
多$54.7M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
4.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $190.3M | $127.1M |
| 净利润 | $6.1M | — |
| 毛利率 | 67.6% | 51.0% |
| 营业利润率 | 6.6% | -54.6% |
| 净利率 | 3.2% | — |
| 营收同比 | 17.7% | 17.1% |
| 净利润同比 | -52.9% | — |
| 每股收益（稀释后） | $0.03 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LZZLAB
| Q4 25 | $190.3M | $127.1M | ||
| Q3 25 | $190.2M | $115.4M | ||
| Q2 25 | $192.5M | $109.1M | ||
| Q1 25 | $183.1M | $105.7M | ||
| Q4 24 | $161.7M | $108.5M | ||
| Q3 24 | $168.6M | $101.8M | ||
| Q2 24 | $177.4M | $100.1M | ||
| Q1 24 | $174.2M | $87.1M |
净利润LZZLAB
| Q4 25 | $6.1M | — | ||
| Q3 25 | $4.5M | $-36.0M | ||
| Q2 25 | $-266.0K | $-40.7M | ||
| Q1 25 | $5.1M | $-48.4M | ||
| Q4 24 | $12.9M | — | ||
| Q3 24 | $11.1M | $-41.7M | ||
| Q2 24 | $1.3M | $-80.3M | ||
| Q1 24 | $4.7M | $-53.5M |
毛利率LZZLAB
| Q4 25 | 67.6% | 51.0% | ||
| Q3 25 | 67.3% | 59.5% | ||
| Q2 25 | 65.0% | 60.6% | ||
| Q1 25 | 63.7% | 63.6% | ||
| Q4 24 | 67.0% | 61.5% | ||
| Q3 24 | 67.5% | 64.1% | ||
| Q2 24 | 64.1% | 64.9% | ||
| Q1 24 | 60.7% | 61.4% |
营业利润率LZZLAB
| Q4 25 | 6.6% | -54.6% | ||
| Q3 25 | 3.4% | -42.3% | ||
| Q2 25 | -1.6% | -50.3% | ||
| Q1 25 | 4.9% | -53.3% | ||
| Q4 24 | 8.1% | -62.6% | ||
| Q3 24 | 9.6% | -66.6% | ||
| Q2 24 | 0.6% | -76.0% | ||
| Q1 24 | 2.9% | -80.7% |
净利率LZZLAB
| Q4 25 | 3.2% | — | ||
| Q3 25 | 2.4% | -31.2% | ||
| Q2 25 | -0.1% | -37.3% | ||
| Q1 25 | 2.8% | -45.8% | ||
| Q4 24 | 7.9% | — | ||
| Q3 24 | 6.6% | -40.9% | ||
| Q2 24 | 0.7% | -80.2% | ||
| Q1 24 | 2.7% | -61.4% |
每股收益（稀释后）LZZLAB
| Q4 25 | $0.03 | $-0.05 | ||
| Q3 25 | $0.02 | $-0.03 | ||
| Q2 25 | $0.00 | $-0.04 | ||
| Q1 25 | $0.03 | $-0.04 | ||
| Q4 24 | $0.07 | $-0.09 | ||
| Q3 24 | $0.06 | $-0.04 | ||
| Q2 24 | $0.01 | $-0.08 | ||
| Q1 24 | $0.02 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $203.1M | $689.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $171.9M | $715.5M |
| 总资产 | $511.5M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LZZLAB
| Q4 25 | $203.1M | $689.6M | ||
| Q3 25 | $237.2M | $717.2M | ||
| Q2 25 | $217.0M | $732.2M | ||
| Q1 25 | $210.0M | $757.3M | ||
| Q4 24 | $142.1M | $779.7M | ||
| Q3 24 | $112.5M | $616.1M | ||
| Q2 24 | $118.8M | $630.0M | ||
| Q1 24 | $228.1M | $650.8M |
股东权益LZZLAB
| Q4 25 | $171.9M | $715.5M | ||
| Q3 25 | $201.9M | $759.9M | ||
| Q2 25 | $194.1M | $791.7M | ||
| Q1 25 | $187.2M | $810.8M | ||
| Q4 24 | $93.3M | $840.9M | ||
| Q3 24 | $60.1M | $667.7M | ||
| Q2 24 | $60.8M | $704.2M | ||
| Q1 24 | $167.9M | $762.2M |
总资产LZZLAB
| Q4 25 | $511.5M | $1.2B | ||
| Q3 25 | $551.1M | $1.2B | ||
| Q2 25 | $543.0M | $1.2B | ||
| Q1 25 | $532.7M | $1.2B | ||
| Q4 24 | $373.9M | $1.2B | ||
| Q3 24 | $348.8M | $985.3M | ||
| Q2 24 | $359.5M | $987.4M | ||
| Q1 24 | $459.7M | $988.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $34.1M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $28.0M | $-26.7M |
| 自由现金流率自由现金流/营收 | 14.7% | -21.0% |
| 资本支出强度资本支出/营收 | 3.2% | 0.5% |
| 现金转化率经营现金流/净利润 | 5.63× | — |
| 过去12个月自由现金流最近4个季度 | $147.9M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流LZZLAB
| Q4 25 | $34.1M | $-26.0M | ||
| Q3 25 | $54.2M | $-32.0M | ||
| Q2 25 | $39.1M | $-31.0M | ||
| Q1 25 | $50.7M | $-61.7M | ||
| Q4 24 | $42.6M | $-55.8M | ||
| Q3 24 | $31.6M | $-26.8M | ||
| Q2 24 | $27.2M | $-42.2M | ||
| Q1 24 | $34.2M | $-90.1M |
自由现金流LZZLAB
| Q4 25 | $28.0M | $-26.7M | ||
| Q3 25 | $47.0M | $-35.0M | ||
| Q2 25 | $31.6M | $-33.9M | ||
| Q1 25 | $41.3M | $-63.2M | ||
| Q4 24 | $35.9M | $-58.4M | ||
| Q3 24 | $22.0M | $-28.2M | ||
| Q2 24 | $17.4M | $-42.9M | ||
| Q1 24 | $24.7M | $-91.1M |
自由现金流率LZZLAB
| Q4 25 | 14.7% | -21.0% | ||
| Q3 25 | 24.7% | -30.4% | ||
| Q2 25 | 16.4% | -31.1% | ||
| Q1 25 | 22.6% | -59.9% | ||
| Q4 24 | 22.2% | -53.8% | ||
| Q3 24 | 13.0% | -27.7% | ||
| Q2 24 | 9.8% | -42.9% | ||
| Q1 24 | 14.2% | -104.5% |
资本支出强度LZZLAB
| Q4 25 | 3.2% | 0.5% | ||
| Q3 25 | 3.8% | 2.6% | ||
| Q2 25 | 3.9% | 2.6% | ||
| Q1 25 | 5.1% | 1.5% | ||
| Q4 24 | 4.1% | 2.4% | ||
| Q3 24 | 5.7% | 1.3% | ||
| Q2 24 | 5.6% | 0.7% | ||
| Q1 24 | 5.4% | 1.1% |
现金转化率LZZLAB
| Q4 25 | 5.63× | — | ||
| Q3 25 | 12.03× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 9.89× | — | ||
| Q4 24 | 3.31× | — | ||
| Q3 24 | 2.86× | — | ||
| Q2 24 | 20.74× | — | ||
| Q1 24 | 7.21× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LZ
暂无分部数据
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
